ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 609,15
-0,69%
Dow Jones
39 127,80
0,04%
DAX
18 155,24
-0,04%
Brent Oil
84,435
0,30%
Bitcoin
60 833,21
-1,58%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. USOTC
  6. Acura Pharmaceuticals Inc (CE) (ACUR)

  7. Acura Pharmaceuticals Inc (CE) (ACUR) Actualités

ACUR

Acura Pharmaceuticals (CE) (ACUR)

Acura Pharmaceuticals Inc (CE)
De:
Trier par:
 Showing the most relevant articles for your search:USOTC:ACUR
DateHeureSourceTitreSymboleSociété
04/06/202417h00Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
15/05/202414h00Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:ACURAcura Pharmaceuticals Inc (CE)
02/01/202421h23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ACURAcura Pharmaceuticals Inc (CE)
30/06/202319h00Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]USOTC:ACURAcura Pharmaceuticals Inc (CE)
28/06/202314h01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ACURAcura Pharmaceuticals Inc (CE)
15/05/202319h02Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:ACURAcura Pharmaceuticals Inc (CE)
05/01/202322h10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ACURAcura Pharmaceuticals Inc (CE)
31/03/202222h13Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:ACURAcura Pharmaceuticals Inc (CE)
14/02/202218h55Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:ACURAcura Pharmaceuticals Inc (CE)
15/11/202122h53Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ACURAcura Pharmaceuticals Inc (CE)
01/06/202122h11Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)USOTC:ACURAcura Pharmaceuticals Inc (CE)
12/04/202116h01Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:ACURAcura Pharmaceuticals Inc (CE)
31/03/202122h17Edgar (US Regulatory)Annual Report (10-k)USOTC:ACURAcura Pharmaceuticals Inc (CE)
07/08/201920h51Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:ACURAcura Pharmaceuticals Inc (CE)
12/07/201916h02Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)USOTC:ACURAcura Pharmaceuticals Inc (CE)
31/07/201822h09Edgar (US Regulatory)Withdrawal of Registration Statement (rw)USOTC:ACURAcura Pharmaceuticals Inc (CE)
10/04/201815h42Edgar (US Regulatory)Confidential Treatment Order (ct Order)USOTC:ACURAcura Pharmaceuticals Inc (CE)
14/02/201814h56Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:ACURAcura Pharmaceuticals Inc (CE)
22/01/201813h01Edgar (US Regulatory)Amended Current Report Filing (8-k/a)USOTC:ACURAcura Pharmaceuticals Inc (CE)
27/09/201723h23Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:ACURAcura Pharmaceuticals Inc (CE)
03/08/201717h48Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:ACURAcura Pharmaceuticals Inc (CE)
28/07/201715h38Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:ACURAcura Pharmaceuticals Inc (CE)
14/03/201715h15Edgar (US Regulatory)(25-NSE)USOTC:ACURAcura Pharmaceuticals Inc (CE)
15/02/201722h15GlobeNewswire Inc.Acura Pharmaceuticals Common Stock To Trade On The OTCQB MarketUSOTC:ACURAcura Pharmaceuticals Inc (CE)
03/02/201723h17Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:ACURAcura Pharmaceuticals Inc (CE)
03/01/201722h15GlobeNewswire Inc.Acura Pharmaceuticals Exploring Strategic AlternativesUSOTC:ACURAcura Pharmaceuticals Inc (CE)
18/10/201612h30GlobeNewswire Inc.KemPharm Announces Licensing Agreement with Acura Pharmaceuticals for Aversion®  Abuse-Deterrent TechnologyUSOTC:ACURAcura Pharmaceuticals Inc (CE)
31/03/201612h01Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:ACURAcura Pharmaceuticals Inc (CE)
23/03/201622h12Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)USOTC:ACURAcura Pharmaceuticals Inc (CE)
09/03/201622h11Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)USOTC:ACURAcura Pharmaceuticals Inc (CE)
 Showing the most relevant articles for your search:USOTC:ACUR

Dernières Valeurs Consultées

AMEX
GRF
Eagle Capital Growth
ASX
PESHA
Pepper Residential Secur...
USOTC
SGBCF
Shanghai Henlius Biotech (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés